Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 169
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are climate change and air pollution triggering cardiovascular disease?

Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

How does our blood absorb light?

Light has been shown to have anti-depressant effects (just think about your mood when it's sunny!). But...

Understanding the perspective of women who use the Billings Ovulation Method

Fertility awareness-based methods (FABM) are a group of family planning methods that teach women how to...

Backer Badge Funded